Effects of smoking on very-long term mortality after first ST elevation myocardial infarction
Creators
- 1. Gazi University, School of Medicine, Cardiology Department, Ankara (Turkey)
- 2. Necmettin Erbakan University, School of Medicine, Cardiology Department, Konya (Turkey)
- 3. Karabük University, School of Medicine, Cardiology Department, Karabük (Turkey)
- 4. Selçuk University, School of Medicine, Cardiology Department, Konya (Turkey)
- 5. Erciyes University, School of Medicine, Cardiology Department, Kayseri (Turkey)
- 6. KTU Karatay University, Medicana Hospital, Cardiology Department, Konya (Turkey)
Description
Background: The smoking paradox has been a matter of debate for acute myocardial infarction patients for more than two decades. Although there is huge evidence claiming that is no real paradox, publications supporting better outcomes in post-MI smokers are still being released. Objective: To explore the effect of smoking on very long-term mortality after ST Elevation myocardial infarction (STEMI). Methods: This study included STEMI patients who were diagnosed between the years of 2004-2006 at three tertiary centers. Patients were categorized according to tobacco exposure (Group 1: non-smokers; Group 2: <20 package⁎ years users, Group 3: 20-40 package⁎ years users, Group 4: >40 package⁎ years users). A Cox regression model was used to estimate the relative risks for very long-term mortality. P value <0.05 was considered as statistically significant. Results: There were 313 patients (201 smokers, 112 non-smokers) who were followed-up for a median period of 174 months. Smokers were younger (54±9 vs. 62±11, p: <0.001), and the presence of cardiometabolic risk factors were more prevalent in non-smokers. A univariate analysis of the impact of the smoking habit on mortality revealed a better survival curve in Group 2 than in Group 1. However, after adjustment for confounders, it was observed that smokers had a significantly increased risk of death. The relative risk became higher with increased exposure (Group 2 vs. Group 1; HR: 1.141; 95% CI: 0.599 to 2.171, Group 3 vs Group 1; HR: 2.130; 95% CI: 1.236 to 3.670, Group 4 vs Group 1; HR: 2.602; 95% CI: 1.461 to 4.634). Conclusion: Smoking gradually increases the risk of all-cause mortality after STEMI. (author)
Additional details
Publishing Information
- Journal Title
- Arquivos Brasileiros de Cardiologia (Online)
- Journal Volume
- 118
- Journal Issue
- 1
- Journal Page Range
- p. 24-32
- ISSN
- 1678-4170
INIS
- Country of Publication
- Brazil
- Country of Input or Organization
- Brazil
- INIS RN
- 53039818
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BIOMEDICAL RADIOGRAPHY; CORONARIES; DIAGNOSIS; MORTALITY; MYOCARDIAL INFARCTION; NICOTINE; PATIENTS; REGRESSION ANALYSIS; RISK ASSESSMENT; SIDE EFFECTS; TOBACCO; TOBACCO SMOKES
- Descriptors DEC
- AEROSOLS; ALKALOIDS; AMINES; ARTERIES; AUTONOMIC NERVOUS SYSTEM AGENTS; AZINES; AZOLES; BLOOD VESSELS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COLLOIDS; DIAGNOSTIC TECHNIQUES; DISEASES; DISPERSIONS; DRUGS; HETEROCYCLIC COMPOUNDS; MATHEMATICS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PARASYMPATHOLYTICS; PARASYMPATHOMIMETICS; PYRIDINES; PYRROLES; PYRROLIDINES; RADIOLOGY; RESIDUES; SMOKES; SOLS; STATISTICS